Metraipolis › archive › dc_0ca6939b6feb
Sensorineural hearing loss in anti-interleukin-1 treated CAPS patients: risk factors and real-life barriers-an observational study — Europe PMC PMID:40748728
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40748728
- DOI
- 10.1093/rheumatology/keaf355
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T02:55:38.508Z
- SHA-256 of the archived text
4dbe1a3b2731f30551cf1d40ad33864b699fec400a8aa1cbd8acf4a8d0eb3328- Stable URL of this page
https://metraipolis.com/documento/dc_0ca6939b6feb
How to cite
Sensorineural hearing loss in anti-interleukin-1 treated CAPS patients: risk factors and real-life barriers-an observational study — Europe PMC PMID:40748728 — Europe PMC (en), https://europepmc.org/article/MED/40748728 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0ca6939b6feb (Metraipolis archive dc_0ca6939b6feb, sha256 4dbe1a3b2731f30551cf1d40ad33864b699fec400a8aa1cbd8acf4a8d0eb3328)
BibTeX
@misc{dc0ca6939b6feb,
title = {Sensorineural hearing loss in anti-interleukin-1 treated CAPS patients: risk factors and real-life barriers-an observational study — Europe PMC PMID:40748728},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40748728},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0ca6939b6feb; sha256 4dbe1a3b2731f30551cf1d40ad33864b699fec400a8aa1cbd8acf4a8d0eb3328},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40748728. Agents can read the archived copy with the MCP tool read_document.